Catalyst Health Ventures
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of its strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Our disciplined investment process leverages both intellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. For more information on Catalyst Health Ventures, visit: www.catalysthealthventures.com.
RA Capital takes an evidence-based approach to investing globally in innovative healthcare and life sciences companies. We strive to recognize success early and to appreciate the full extent of value creation of which a company is capable. Our breadth of research and unique business structure, which accommodates both public and private investments, helps our portfolio integrate what we believe are the most compelling opportunities for value creation in our industry. Our understanding of scientific and business risks and best practices is derived from our well-curated collection of thousands of case studies that document the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability. We make our knowledge base available to our portfolio companies and, through our outreach efforts, to the broader healthcare and life science community.
Mass Medical Angels
Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments. Our mission is to bring more clinical tools to the marketplace, while attaining superior returns for our investors. To do this, we provide financing and mentoring to early-stage life-science companies so that they can obtain further funding, reach positive cash-flows or get acquired. MA2 members are carefully vetted for their deep expertise around the health sciences. Many of them have been researchers, clinicians, venture capitalists, executives, consultants, engineers, bankers or attorneys. They bring a willingness to support early stage companies to further our mission. In addition, we draw on our deep relationships with the institutions in Boston healthcare supercluster, the leading healthcare innovation center in the world. They provide additional resources, including deal flow, expertise and advisors for the companies we work with. http://www.massmedangels.com/